Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved
- PMID: 36004540
- PMCID: PMC9574549
- DOI: 10.1210/endocr/bqac141
Understanding How Pregnancy Protects Against Ovarian and Endometrial Cancer Development: Fetal Antigens May Be Involved
Abstract
It is well known that many factors, including infertility, obesity, type 2 diabetes, and family history of cancer, increase the risk of developing endometrial and ovarian cancer. However, multiparous women are known to have a lower risk of developing either ovarian or endometrial cancer than nonparous women. The lack of ovulation and shifting of sex hormonal balance, with decreased estrogen levels and increased progesterone levels during pregnancy, has traditionally been thought to be the major contributor to this decreased risk. However, in reality, the mechanisms underlying this phenomenon are relatively unknown. Increasing evidence suggests that endocrine factors are unlikely to completely explain the protective effect of pregnancies, and that multiple other nonendocrine mechanisms including fetal antigens and the newly proposed dormant cells hypothesis may also be involved. In this review, we summarize recent evidence and describe the potential underlying mechanisms that may explain how pregnancy protects against the development of ovarian and endometrial cancers in women's later life.
Keywords: endocrinal factors; endometrial cancer; fetal antigens; ovarian cancer; pregnancy; protection.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society.
Similar articles
-
The prevention of breast cancer through reduced ovarian steroid exposure.Acta Oncol. 1992;31(2):167-74. doi: 10.3109/02841869209088898. Acta Oncol. 1992. PMID: 1622631 Review.
-
Sex steroids and breast cancer prevention.J Natl Cancer Inst Monogr. 1994;(16):139-47. J Natl Cancer Inst Monogr. 1994. PMID: 7999456 Review.
-
[Oral contraceptives and endometrial and ovarian carcinomas].Gynakol Geburtshilfliche Rundsch. 1998;38(2):105-8. doi: 10.1159/000022244. Gynakol Geburtshilfliche Rundsch. 1998. PMID: 9815528 Review. German.
-
Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.Cancer Res. 1999 Aug 1;59(15):3658-62. Cancer Res. 1999. PMID: 10446978
-
Role of estrogens and progesterone in the etiology and prevention of endometrial cancer: review.Am J Obstet Gynecol. 1983 Jul 15;146(6):696-707. doi: 10.1016/0002-9378(83)91014-1. Am J Obstet Gynecol. 1983. PMID: 6307050 Review.
Cited by
-
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025. Sultan Qaboos Univ Med J. 2025. PMID: 40657466 Free PMC article.
-
Endometrial cancer and simultaneous pregnancy, an unusual combination. Case report.J Obstet Gynaecol Res. 2025 Jan;51(1):e16147. doi: 10.1111/jog.16147. Epub 2024 Nov 8. J Obstet Gynaecol Res. 2025. PMID: 39513540 Free PMC article.
-
Association of Pregnancy Complications with Endometrial or Ovarian or Breast Cancer: A Case Control Study.Medicina (Kaunas). 2024 Dec 24;61(1):1. doi: 10.3390/medicina61010001. Medicina (Kaunas). 2024. PMID: 39858983 Free PMC article.
-
The clinicopathological role of miRNA-196a and its SNP variant rs11614913 in high-grade ovarian cancer.Prz Menopauzalny. 2024 Dec;23(4):180-184. doi: 10.5114/pm.2024.145949. Epub 2024 Dec 22. Prz Menopauzalny. 2024. PMID: 39811383 Free PMC article.
-
Ovarian Dysgerminoma Associated With Pregnancy Presenting as Hemoperitoneum: An Obstetric Case Report.Clin Case Rep. 2025 Feb 14;13(2):e70203. doi: 10.1002/ccr3.70203. eCollection 2025 Feb. Clin Case Rep. 2025. PMID: 39959557 Free PMC article.
References
-
- Ferlay J, Colombet M, Soerjomataram I, et al. . Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149:778–789. - PubMed
-
- Sung H, Ferlay J, Siegel RL, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. - PubMed
-
- Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531–1543. - PubMed
-
- Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105(5):493–499. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical